Animal Testing And Non-Animal Alternative Testing Market 2023 - By Size, Segmentation, Application, Outlook And Opportunities Analysis By 2032

As per The Business Research Company's Animal Testing And Non-Animal Alternative Testing Opportunities And Strategies Market Report 2023, The global animal testing market was valued at $10.74 billion in 2019 and the market is expected to grow at a compound annual growth rate (CAGR) of 3.38% during 2019-2025 and at a CAGR of 2.13% during 2025-2035. USA and Japan are the major animal testing markets in the world. The USA's animal testing market was valued at $4.67 billion in 2019, and is expected to grow at a CAGR of 1.27% during 2019-2025 and at a CAGR of 0.63% during 2025-2035. Japan's animal testing market was valued at $1.03 billion in 2019. The market is forecast to grow at a CAGR of 3.12% during 2019-2025, and at a CAGR of 1.25% during 2025-2035.

The rise in need for preclinical studies for the approval of therapeutics is expected to contribute to the growth of the market. The need for preclinical studies is on the rise as the researchers gain insights on new drug candidates' dosing and toxicity while conducting these studies in animal models. Preclinical studies provide information about the safety and efficacy of a drug candidate before testing it in humans. The studies require appropriate preclinical models that are comparable to the target population to ensure reliable results. According to clinicalTrials.gov, a web-based resource which provides data on clinical studies, as of March 2021, there were 448,408 clinical studies registered. Thus, with the growing need for drug discovery and development, the need for animal models in preclinical studies is also growing contributing to the growth of the animal testing market.

View Complete Report @ https://www.thebusinessresearchcompany.com/report/animal-testing-and-non-animal-alternative-testing-market

The OOC (organ-on-chip) tools for testing are gaining popularity in the non-animal alternatives testing market. OOCs are miniature tissues and organs grown in-vitro that enable the modeling of human physiology and disease. OOCs are now being explored worldwide as tools for developing disease models and accurately predicting drug efficacies and toxicities. The advantages of OOCs over cell culture, animal models, and human clinical trials have captured the attention of both the medical and pharmaceutical communities focusing on developing targeted therapies. For instance, in April 2020, researchers at the Massachusetts Institute of Technology (MIT) in the US, developed a new model for Organ-on-Chip to develop treatments for inflammatory diseases and afflictions.

The top opportunities in the animal testing and non-animal alternative testing market segmented by type will arise in the animal testing segment, which will gain $2.37 billion of global annual sales by 2025 and $3.08 billion of global annual sales by 2035. The animal testing market size will gain the most in Rest of the World at $1.44 billion in 2025 and $3.62 billion in 2035. The non-animal alternative testing market size will gain the most in Europe at $0.50 billion in 2025 and $2.17 billion in 2035.

Animal Testing And Non-Animal Alternative Testing Market Segmentation:
The animal testing market is segmented by end use industrial application.
By End Use Industrial Application -
a) Pharmaceuticals
b) Academic Research
c) Medical Devices
d) Chemicals And Pesticides
e) Cosmetics
f) Other end users

Major players in the Animal Testing And Non-Animal Alternative Testing market include Cyprotex, Bio-Rad Laboratories, Inc., BioIVT, Emulate, Inc, MatTek Corporation.

The regions covered in the global Animal Testing And Non-Animal Alternative Testing market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=2755&type=smp

The latest report from The Business Research Company, 'Global Animal Testing And Non-Animal Alternative Testing Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Animal Testing And Non-Animal Alternative Testing Market Report Table Of Content
1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
………………………………………..
25. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market
26. Non-Animal Alternatives Testing Competitive Landscape And Company Profiles
27. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies
28. Conclusions & Recommendations
29. Appendix

PURCHASE the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2755

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

This release was published on openPR.